The Sunstone Health Podcast

Today, Josh Resnikoff and Justin Starbird sat down with Dr. Clint Phillips, the visionary founder of Medi.ci and  2nd.MD. After his daughter, Gabby, was paralyzed by a stroke at birth and his family was met with a grueling four-month wait for the wrong specialist, Clint dedicated his life to removing the friction from healthcare.We explore the transformation from providing virtual second opinions for Fortune 500 companies to launching Dr. Gabi. The first AI capable of performing clinical-grade face scans, reading vitals, and writing prescriptions. Josh and Clint discuss why the diagnostic odyssey is a failure of architecture and how the future of medicine lies in the technical glue of AI and prevention.Key Highlights:Clint shares the heartbreaking reality of waiting months for a specialist who didn't treat his daughter’s condition. That same frustration that drove Josh to begin the engineering behind Sunstone.A look at the technology behind Dr. Gabi, an AI that reads blood flow through a smartphone camera to detect blood pressure, stress, and stroke risk.Why the current system spends $10,000 on a crisis but refuse to spend $1,000 on the love and data required to prevent it.How 2nd.MD scaled to 9 million members by proving to 300 Fortune 500 companies that getting the right diagnosis early is the ultimate ROI.The launch of the first AI-driven prescription platform and how it’s being positioned to help everyone from high-end executives to Medicaid recipients."We aren't just managing symptoms; we are building the loop that gets people exactly the care they need, 20 times faster than the status quo."

"Once you see the gears of the system moving against the patient, you can’t unsee them. You either stay part of the machine, or you start engineering the alternative." – Emma Fox, Founder of FoxWatch In this episode of the Sunstone Health Podcast, we are joined by Emma Fox, the Founder of FoxWatch and one of the industry's most vocal advocates for employer transparency. After two decades on the dark side of major carriers, Emma pivoted to a mission of neutral interrogation. She began auditing the waste, hidden kickbacks, and misaligned incentives that keep the diagnostic odyssey alive.Josh and Emma strip away industry jargon to discuss the humanitarian problem hidden in balance sheets. From the moral whiplash of $5 million industry parties to the clinical cost of denied autism treatments, this conversation is a briefing on how to spot the ick in your health plan and why the broker breakup is often the first step toward clinical clarity.Key Highlights:Emma recounts the moment she realized premium dollars were being diverted to naming rights while members were being forced through step therapy for life-saving meds.Why curiosity is the most dangerous trait an employee can have in a system built on opacity.The accidental origin of the YouPowered Symposium and how a guerrilla force of ethical advisors is building the alternative to the status quo.Why a 48% increase in premiums is a failure of leadership, and how to reclaim ownership of health plan data.Emma and Josh discuss the personal toll of navigating autism diagnoses and why ‘wait and see’ is a failed clinical strategy.

In this episode of the Sunstone Health Podcast, CEO Josh Resnikoff discusses the philosophy of business for good. Moving beyond the cliché of social impact, Josh breaks down how Sunstone Health is built on a framework of pathological optimism. The belief that data-driven efficiency opens the door by saving money, but the real mission is the lives it saves. Josh explores the tension between fiduciary responsibility and humanitarian missions, explaining why Sunstone refuses to take a dollar out of one pocket to put it in another. Instead,  positioning Sunstone as the technical glue that aligns the incentives of health plans, employers, and families to solve the $1 trillion diagnostic odyssey.Key Highlights in this Episode:Answers the adage that do no harm isn't enough anymore. Josh explains why we must move faster to prevent the harm caused by diagnostic delay.How Sunstone’s model ensures that every success for the business is a direct victory for a child with a developmental delay.A look at how Sunstone bridges the gap between the actuaries at the plan and the clinicians at the bedside.Josh shares his band-of-brothers philosophy on legacy and the grit required to get back on the horse."I believe you can do both: you can be a good steward of capital and still center yourself in doing good."

In the first episode of 2026, Josh Resnikoff explains the evolution of TMA Precision Health into Sunstone Health. This rebrand is a tactical pivot toward ending the diagnostic odyssey for children with developmental delay patterns.Josh reveals the personal and historical inspiration behind the name Sunstone. A Viking navigational tool used to find the sun on stormy days, and how that same secret technology now drives Sunstone’s claims-level interrogation to find the invisible patients hidden in healthcare data.Key Highlights in this Episode:Why 2026 was the definitive time to move from broad impact to a focused application of rescue engineering.The Faroese history of the Sunstone and how it mirrors Sunstone’s ability to illuminate a path through cloudy healthcare data.Josh discusses the shift from doing God's work to proving the fiduciary win for employers and stop-loss insurers.Josh reflects on his own son’s ongoing odyssey and why it feels irresponsible not to scale this solution to every family in need."The system is misaligned. We’ve built the engine to smooth out the friction."

The healthcare system is desperate for a solution that actually works. 🛡️In our final episode as TMA Precision Health, Josh Resnikoff and Justin Starbird reflect on a year of explosive growth, from a pilot to 250,000 lives in a single weekend. But this isn't just a victory lap.We’re closing the chapter on TMA to make room for a massive evolution. We’ve sharpened our blade on pediatric epilepsy, and now we’re scaling our engine to fight for every child with a developmental delay.Listen in as we discuss:Why "Be Patient" is a failed treatment plan.The $1.5M community investment from the families we fight for.Why we’re setting "impossible goals" for 2026.The system isn't delivering. We are. Press play to hear the future of our mission. 🧬

Years of specialist visits. No answers. Billions wasted. That's the Diagnostic Odyssey, and our Automation Architect, Cameron Pearson, is helping build the engine to end it.Cam shares his personal, frustrating experience with his own father’s rare disease journey and explains why he left his successful career to join our fight.This isn't just tech talk. This is about using AI for human good:Why did Cam leave traditional tech consulting? He realized he could use his skills to fight for families rather than just boost corporate sales.Hear Cam break down how our cutting-edge, agentic AI system safely takes on the healthcare system's complexity, shrinking years of uncertainty into just 12 weeks."We are not leveraging technology to replace low-level jobs. We are using it in a very humanitarian way."If you're tired of hearing about AI that doesn't solve real problems, tune in. This is the story of how a personal mission became the blueprint for disrupting a $1 trillion mess.Press play to meet an engineer powering change.

In this episode of the Sunstone Health Podcast, we are joined by TMA Precision Health CEO Josh Resnikoff and the internationally recognized physician, engineer, and TMA Advisor Dr. Paul Carney for a conversation about confronting the systemic failures in rare disease diagnostics. Together, we explore the moral imperative behind TMA’s work, the crucial role of AI, and how combining elite clinical expertise with technology is reshaping the standard of care.Dr. Carney shares his decades of experience on the clinical front lines, providing chilling examples of patients, from those with severe epilepsy to a child with brain leukemia, whose lives were severely impacted because vital diagnostic information was present but misinterpreted. He argues that traditional medical training is now obsolete for handling the 15,000+ known rare diseases, concluding that the 6 to 7 year diagnostic odyssey is due to systemic throughput failure. Josh connects this clinical struggle to his personal journey as a parent, explaining why building TMA became a moral crusade to ensure other families don't face the same emotional and financial uncertainty.They reflect on the powerful and rare convergence of data and opportunity currently driving the field. Dr. Carney details how he acts as the "doctor in the box," viewing TMA's advanced AI and genetic data platform as the necessary extension of his clinical practice. This fusion allows TMA to handle the vast computational task of pattern recognition, freeing up human doctors to focus on judgment, empathy, and decision-making. The goal is to establish genetic testing as a routine front-line tool, bringing actionable precision medicine to scale.This episode is an inspiring and deeply strategic look at the clinical urgency and engineering ingenuity behind TMA Precision Health, and the leaders working every day to bring clarity to families who have been searching for years.Tune in to understand the strategic and ethical reasoning behind TMA’s mission to end the diagnostic odyssey.

In this special wrap-up episode of the Sunstone Health Podcast, TMA Precision Health CEO & Co-Founder Josh Resnikoff, Director of Operations Sofia Giraldo, and Co-Host Justin Starbird come together for a heartfelt conversation about their recent experience at Epilepsy Awareness Day at Disneyland.What begins as a lighthearted catch-up quickly unfolds into one of the most emotional and inspiring discussions yet. Together, the team reflects on the incredible energy, courage, and community they witnessed as they met families navigating rare epilepsies, many of whom have spent years searching for answers.Josh and Sofia share deeply personal takeaways from being face-to-face with patients and caregivers, often for the first time in this capacity. From families traveling across states just to access genetic testing, to young advocates who view their condition as a superpower, the event provided a powerful reminder of why TMA’s mission matters.Listeners will hear:What made Epilepsy Awareness Day unlike any other event the team has attendedHow it felt to provide on-site genomic testing, a first in the event’s 12-year history!The emotional impact of hearing families’ diagnostic journeys firsthandWhy this experience renewed the team's commitment to accelerating answers for rare disease communitiesThe significance of community, advocacy, and hope in the rare epilepsy spaceThis episode is a moving reflection on purpose, humanity, and the real-world impact of bringing precision medicine directly to families in need.

In this episode of the Sunstone Health Podcast, we sit down with TMA Precision Health’s Director of Operations, Sofia Giraldo, for a heartfelt conversation about the mission to end the diagnostic odyssey for families worldwide. Together, we explore the impact of TMA’s work, the lessons learned from early pilot programs, and how passion, purpose, and innovation are reshaping rare disease care.Sofia shares her remarkable journey from growing up in Colombia surrounded by healthcare, to helping launch TMA’s first pilot program during the pandemic, to eventually moving to the United States to join the team full-time. She opens up about what it was like to reconnect with TMA after completing her MBA in Boston, how her global perspective has shaped her work, and why the rare disease community has become so personal and meaningful to her.Sofia reflects on the powerful moments she’s witnessed. Families traveling hours for the chance at answers, children bravely stepping forward for genome sequencing, and the shared hope that fills events like Epilepsy Awareness Day. She also discusses what it takes to run large-scale operations across countries, the lessons learned from early pilots, and how AI and human insight are helping TMA expand access to life-changing diagnostics.This episode is an inspiring look at the heart, hustle, and humanity behind TMA’s mission, and the people working every day to bring clarity to families who have been searching for years.Tune in and get a behind-the-scenes look at how purpose, passion, and innovation are rewriting the future of rare disease care.

In the world of rare diseases, where challenges often feel insurmountable, the power of collaboration shines as a beacon of hope. The latest episode of the Sunstone Health Podcast, "Allies in Action," dives deep into this crucial topic, featuring TMA Precision Health CEO Josh Resnikoff. He shares invaluable insights into how strategic partnerships are not just beneficial, but absolutely essential for boosting exposure, awareness, and growth in rare-disease innovation.Josh emphasizes that genuine relationships are the lifeblood of this vital field. It's not about transactional exchanges, but about forging true alliances that align missions and amplify impact. He highlights the difference between a strategic partnership, one built on shared goals and long-term vision, and a purely transactional one. The former, he explains, is what truly moves the needle, expanding TMA's reach not just to patients and families, but also to clinicians, researchers, and policymakers.The episode also touches on the importance of awareness campaigns, like Epilepsy Awareness Day, in amplifying messages and reshaping public perception of what's possible in rare-disease care. Through compelling storytelling within these alliances, the human element of rare diseases comes to the forefront, fostering empathy and driving action.Josh's journey is a testament to the grit, patience, and passion required to make a real difference. He shares how building a robust network takes time, consistent effort, and a willingness to connect with others who share a common purpose. It's a journey of learning, earning trust, and continuously striving to enrich the entire ecosystem."Allies in Action" is more than just a podcast episode; it's an inspiring call to embrace collaboration, cultivate meaningful relationships, and work together to create a better world for those affected by rare diseases. Tune in to hear how these alliances are accelerating impact and bringing hope to countless families.

Join us for an incredibly inspiring conversation with Brad Levy, the visionary behind Sophie's Journey and Epilepsy Awareness Day (EAD). Brad shares with us the deeply personal story that ignited his mission: his daughter Sophie's battle with epilepsy. Discover how a family's determination to give back to the epilepsy community has blossomed into EAD, an annual event that has grown from a modest gathering to expecting 6,000 guests this year at Disneyland!Tune in as Brad explores the unique experience of EAD, blending top-tier education from epileptologists with a welcoming environment that encourages families to engage with medical experts.Learn about the "super highway" to care that EAD creates, connecting families with crucial resources, specialists, and clinical trial opportunities. TMA Precision Health is proud to be part of Brad's mission this year, bringing its expertise in innovative medical solutions to EAD. By connecting families with cutting-edge care, patient-centered technologies, and meaningful resources, TMA is excited to amplify the impact of EAD while advancing its own mission of transforming lives through precision health. Don’t miss this heartfelt conversation about resilience, innovation, and the power of coming together to make a difference in the lives of those affected by epilepsy!

Join us on this episode of the Sunstone Health Podcast, as host Justin Starbird sits down with Josh Resnikoff, CEO and founder of TMA Precision Health. Dive even deeper into the personal journey that fueled Josh’s journey, the creation of TMA, and its powerful mission to transform patient care.Uncover the strategic brilliance behind TMA Precision Health's impact on healthcare:Hear how TMA is making waves in the healthcare market by strategically partnering with self-funded employers.Josh reveals the crucial concept of the "financial unlock" in MedTech, explaining why healthcare solutions must deliver tangible financial benefits to insurance companies to achieve widespread impact.He also shares the real-world challenges and triumphs of navigating the employer-based healthcare landscape, including the art of tailoring approaches for diverse organizations.Join us to learn about the dedication, innovation, and strategic thinking behind a company striving to make a profound difference in the lives of those affected by rare diseases. This episode is packed with valuable insights for anyone interested in healthcare, entrepreneurship, and the power of personal mission.

Ever wonder what truly drives someone to change the world? In our very first episode, host Justin Starbird sits down with Josh Resnikoff, the founder of TMA Precision Health, to share the incredibly personal story that sparked a revolution in rare disease care.Josh opens up about his son, Shiloh, and the terrifying, unexplained fevers that plunged their family into months of fear and uncertainty. What began as a desperate search for answers for his own child quickly ignited a powerful mission: to create a healthcare system that's faster, smarter, and more accessible for every family facing a rare disease.You'll hear Josh talk about everything from navigating the confusing world of pediatric care to building cutting-edge technology that connects patients with local doctors, giving them real, actionable insights. He'll share the challenges, the breakthroughs, and why, at the end of the day, it's all about human connection and building a system that truly works for patients, not just profits.Join us for a raw, honest look at the journey behind the mission, the hurdles overcome, and the incredible solutions reshaping rare disease care.

Welcome to The Sunstone Health Podcast, where we don’t just talk about changing healthcare. We show you how it’s being done. Hosted by entrepreneur and storyteller Justin Starbird alongside Joshua Resnikoff, Co-Founder of TMA Precision Health, this show dives deep into the frontlines of rare disease innovation.What We Cover:How TMA transforms a multi-year diagnostic journey into actionable insights in just 12 weeks, through proprietary AI models, deep genome-based analysis, and personalized treatment plans delivered by expert genetic counselors.Conversations with clinicians, technologists, patient advocates, and pharma partners to unpack the science, the technology, and most importantly, the human impact of precision medicine.Behind-the-scenes insights into TMA’s mission-driven culture and approach: building scalable, empathetic solutions to serve rare disease patients faster while driving measurable ROI for health plans.TMA is reshaping rare disease care one patient, one insight, one breakthrough at a time.